Levothyroxine Dose Adjustment During Pregnancy
Simply doubling the levothyroxine dose during pregnancy is not appropriate as a blanket recommendation; instead, increase the dose by 30-50% immediately upon pregnancy confirmation, then titrate based on TSH monitoring every 4 weeks. 1
Recommended Dosing Strategy
For Women Already on Levothyroxine
- Increase levothyroxine by 30-50% (or 12.5-25 mcg/day) as soon as pregnancy is confirmed 1, 2
- This empirical increase should occur immediately, as levothyroxine requirements increase as early as the 5th week of gestation 2
- The mean increase needed is approximately 47% by the first half of pregnancy, plateauing around week 16 2
Monitoring and Titration
- Monitor TSH every 4 weeks until stable, then each trimester 3, 1
- Maintain TSH within trimester-specific reference ranges 1
- For women with pre-existing hypothyroidism, measure TSH and free-T4 as soon as pregnancy is confirmed 1
Evidence for Dose Increases
The magnitude of levothyroxine increase varies considerably:
- Most women (84%) require dose increases during pregnancy 4
- Average increases range from 36-62% depending on trimester and individual factors 4, 5
- The etiology of hypothyroidism significantly affects requirements: women with treated Graves' disease or goiter require the largest increases (up to 51% in second trimester), while those with primary hypothyroidism require smaller increases (16%) 6
Why Not Simply "Double"?
A blanket doubling approach (100% increase) would be excessive for most patients and risks overtreatment:
- The FDA label specifies increases of 12.5-25 mcg/day for pregnant women with pre-existing hypothyroidism 1
- Research demonstrates average increases of 30-50% are typically sufficient 7, 2, 4
- Individual variation is substantial, requiring TSH-guided titration rather than fixed doubling 5, 6
Special Considerations for Inadequately Treated Women
For women known to be hypothyroid but inadequately treated at pregnancy onset, doubling the levothyroxine dose on at least three days per week may be appropriate to rapidly achieve euthyroidism 7. This represents a specific exception where more aggressive dosing is justified.
Clinical Pitfalls to Avoid
- Do not wait to increase the dose—thyroid hormone requirements increase by week 5-8 of gestation 2
- Do not use the same dose throughout pregnancy—requirements plateau around week 16 but remain elevated until delivery 2
- Return to pre-pregnancy dose immediately after delivery 1
- Monitor TSH 4-8 weeks postpartum, as approximately one-third of women may require long-term continuation 8
Outcomes of Inadequate Treatment
Untreated or undertreated hypothyroidism during pregnancy increases risks of: